Drug Discovery
Subscribe to Drug Discovery

The Lead

Hope for an Effective Malaria Therapy with Just One Tablet

April 24, 2015 8:54 am | by Medical University of Vienna | News | Comments

Approximately 584,000 people worldwide die of malaria each year. Read more...

New Gel Medication Delays Release of Drug to Benefit Patients

April 24, 2015 8:38 am | by University of Huddersfield | News | Comments

Gellan gum pharmaceutical development both delays drug release for maximum effect and can be...

Alcoholic Hepatitis Treatments Fail to Keep Patients Alive

April 23, 2015 8:51 am | by Imperial College London | News | Comments

The main drugs used to treat alcoholic hepatitis are not effective at increasing patients'...

Boosting the Malaria Battle-Line

April 23, 2015 8:39 am | by University of Melbourne | News | Comments

Researchers have discovered how the malaria parasite protects itself by building resistance...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

New Candidate Drug 'Dials Down' Protein Synthesis

April 22, 2015 12:07 pm | by University at Buffalo | News | Comments

UB researcher contributes to study on new candidate drug that may help treat misfolded protein diseases like CMT, Alzheimer’s and Parkinson’s. Read more...

Takeda: Research Collaboration with Keio University School of Medicine, Niigata University

April 21, 2015 3:36 pm | News | Comments

This will focus on the search for and functional analysis of disease-related RNA-binding proteins. Read more...

Trial Shows Benefit of 'BRCA-targeting' Drug in Prostate Cancer

April 21, 2015 3:00 pm | by Institute of Cancer Research | News | Comments

Men with prostate cancer benefit from treatment with the pioneering drug olaparib. Read more...


Detecting Low-Quality Antimalarial Drugs With a Lab-On-Paper

April 21, 2015 8:40 am | by University of Notre Dame | News | Comments

The colors show whether a medicine contains the expected ingredients and whether fillers or substitute drugs have been added. Read more...

New Drug Combination Shows Promise for Breaking Breast Cancer Resistance

April 20, 2015 4:51 pm | by University of Manchester | News | Comments

Researchers have developed a new combination of drugs which could overcome treatment resistance and relapse in breast cancer. Read more...

Opioid Release Rates Fall After Jail Release

April 20, 2015 10:53 am | by NYU Langone | News | Comments

It has been called a pioneering strategy for treating opioid addiction. Read more...

Researchers Seek New Targets for Ovarian Cancer Treatment

April 20, 2015 10:38 am | by University of Pittsburgh | News | Comments

Identifying molecular changes that occur in tissue after chemotherapy could be crucial in advancing treatments for ovarian cancer. Read more...

Immunotherapy is Not a Curiosity Anymore

April 20, 2015 8:29 am | by Ryan Bushey, Associate Editor | Articles | Comments

One of the main sessions at this year’s Experimental Biology Conference in Boston was the Tang Prize Award lecture. Read more...


Impact of Label-Free Cell-Based Assays and the Holistic Calorimetry Approach

April 17, 2015 10:23 am | by Magnus Jansson, Ph.D., CSO, SymCel Sverige AB | Articles | Comments

New, innovative technology solves challenges in antibiotic resistance and the drug development cycle. Read more...

Synthetic Drugs: Evidence That They Can Cause Cancer

April 17, 2015 8:19 am | by Medical University of Vienna | News | Comments

Synthetic cannabinoids are difficult to identify chemically and the possible unwanted toxic effects that can occur following their consumption have so far barely been investigated. Read more...

Evidence Grows that Melanoma Drugs Benefit Some Lung Cancer Patients

April 17, 2015 8:09 am | by European Society for Medical Oncology | News | Comments

A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma. Read more...

Potential for Prediction of Progression for Early Form of Breast Cancer

April 16, 2015 8:40 am | by University of Manchester | News | Comments

Scientists have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression. Read more...

Novartis Announces New Phase 3 Data from CLL Drug Study

April 16, 2015 8:33 am | News | Comments

CLL, the most commonly diagnosed adult leukemia in Western countries, accounts for approximately 1 in 4 cases of all leukemia. Read more...


Promising Developments in Tackling Resistance to Blood Cancer Drugs

April 14, 2015 8:31 am | by University of Southampton | News | Comments

A new drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of Southampton. Read more...

Eisai, Genomics Plc to Team Up on Large Scale Genotype/Phenotype Data Analysis Project

April 14, 2015 8:18 am | News | Comments

Both companies believe that human genetics and genomics can add great value to the drug development process. Read more...

Research Probes New Targets for Cancer Treatment

April 13, 2015 8:22 am | by University of Aberdeen | News | Comments

New research has identified potential new targets for the treatment of certain types of cancer. Read more...

Ketamine Found to Alleviate Depression

April 13, 2015 8:21 am | by University of Hertfordshire | News | Comments

Researchers have found that Ketamine, which has a reputation as an illicit recreational drug, has an extremely large depression reducing effect. Read more...

First Look at 'Wasabi Receptor' Brings Insight for Pain Drug Development

April 10, 2015 10:51 am | by Peter Farley, UCSF | News | Comments

Protein’s structure will guide hunt for new treatments of inflammation-induced pain. Read more...

Scientists Find Molecular Trigger of Schizophrenia - Like Behaviors

April 10, 2015 10:21 am | by The Scripps Research Institute | News | Comments

The research gives scientists new tools for someday preventing or treating psychiatric disorders such as schizophrenia, bipolar disorder and autism. Read more...

Scientists Awarded $1.2 Million to Find Cancer Drug Candidates

April 9, 2015 12:20 pm | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $1.2 million from the National Cancer Institute of the National Institutes of Health (NIH) to accelerate the development of drug candidates to curb one of the most important drivers of human cancer. Read more...

Vitamin D Link with Depression in Overweight Women

April 9, 2015 8:43 am | by University of Adelaide | News | Comments

Researchers have discovered a previously unknown link between vitamin D and depression in overweight women with polycystic ovary syndrome. Read more...

Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis

April 9, 2015 8:42 am | News | Comments

Actavis has an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Pharmaceuticals Inc., upon the completion of the Phase 2b study. Read more...

Biologists Identify Brain Tumor Weakness

April 9, 2015 8:42 am | by Anne Trafton, MIT | News | Comments

Biologists have discovered a vulnerability of brain cancer cells that could be exploited to develop more-effective drugs against brain tumors. Read more...

Easing the Pain

April 9, 2015 8:41 am | by Queen's University | News | Comments

The combination of two well-known drugs will have unprecedented effects on pain management. Read more...

Allergy Drug Inhibits Hepatitis C in Mice

April 9, 2015 8:41 am | by National Institute of Health | News | Comments

An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice. Read more...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.